Sign in
4

Changes in Ownership

PALISADE BIO, INC. Filed Acc 0001493152-23-023867

CEO, CFO, Director gave up 389 shares (to pay taxes)

  • CEO, CFO, Director acquired 1,309 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Finley John David CEO, CFO, Director 2023-07-03 Option exercise +1,309 7,582 D
Finley John David CEO, CFO, Director 2023-07-06 Shares withheld for taxes −389 $1.76 $686 7,193 D
Derivatives
Finley John David CEO, CFO, Director 2023-07-03 Option exercise · Restricted Stock Units −1,309 2,618 D
Loading xslF345X04/ownership.xml…